At a glance
ClinicalIndex Comparison Record- ✓Obese patients undergoing bariatric surgery (laparoscopic sleeve gastrectomy or laparoscopic Roux-en-Y gastric bypass)
- ✓Age 18 years or older
- ✓Surgical treatment between 01/01/2018 and 12/31/2018
- ✕Age under 18 years
- ✕Opioid use within 30 days of enrollment
- ✕History of chronic pain
- ✕Current use of pregabalin or gabapentin
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Controlled Trial Investigating Use of Liposomal Bupivacaine in Bariatric Surgery
In Brief
A Phase 2 clinical trial evaluating Liposomal Bupivacaine TAP block and Bupivacaine TAP block for Bariatric Surgery Analgesia. Completed, enrolled 219 participants across 1 site.
Detailed Summary
The aim of this study is to perform a randomized controlled trial for patients undergoing bariatric surgery, comparing the need for opiates with and without administration of a transversus abdominis plane (TAP) block using the long acting local anesthetic, liposomal bupivacaine (Exparel®). From this study, the investigators will assess whether use of long acting local anesthetic can reduce the need for opiates in the bariatric population.
Study Details
Timeline
Interventions
Infiltration of the transverse abdominis peritoneum by a local anesthetic under laparoscopic visualization.
Infiltration of the transverse abdominis peritoneum by a local anesthetic under laparoscopic visualization.